nodes	percent_of_prediction	percent_of_DWPC	metapath
Nilutamide—POR—Doxorubicin—kidney cancer	0.269	0.42	CbGbCtD
Nilutamide—CYP2C8—Pazopanib—kidney cancer	0.0739	0.115	CbGbCtD
Nilutamide—CYP2C9—Capecitabine—kidney cancer	0.0538	0.084	CbGbCtD
Nilutamide—CYP2C8—Erlotinib—kidney cancer	0.0527	0.0824	CbGbCtD
Nilutamide—CYP2C8—Paclitaxel—kidney cancer	0.0483	0.0754	CbGbCtD
Nilutamide—CYP2C8—Sorafenib—kidney cancer	0.0429	0.067	CbGbCtD
Nilutamide—CYP2C19—Sorafenib—kidney cancer	0.036	0.0562	CbGbCtD
Nilutamide—CYP2C9—Paclitaxel—kidney cancer	0.0337	0.0526	CbGbCtD
Nilutamide—CYP2C9—Sorafenib—kidney cancer	0.0299	0.0467	CbGbCtD
Nilutamide—CYP2C19—urine—kidney cancer	0.00374	0.211	CbGeAlD
Nilutamide—CYP2C9—urine—kidney cancer	0.0029	0.163	CbGeAlD
Nilutamide—Flutamide—CYP1A1—kidney cancer	0.00236	0.673	CrCbGaD
Nilutamide—POR—nephron tubule—kidney cancer	0.00184	0.104	CbGeAlD
Nilutamide—POR—cortex of kidney—kidney cancer	0.00157	0.0886	CbGeAlD
Nilutamide—POR—cardiac atrium—kidney cancer	0.0015	0.0843	CbGeAlD
Nilutamide—Enzalutamide—ABCB1—kidney cancer	0.00115	0.327	CrCbGaD
Nilutamide—AR—renal system—kidney cancer	0.000988	0.0556	CbGeAlD
Nilutamide—AR—kidney—kidney cancer	0.000956	0.0538	CbGeAlD
Nilutamide—AR—cortex of kidney—kidney cancer	0.000931	0.0524	CbGeAlD
Nilutamide—AR—gonad—kidney cancer	0.000886	0.0499	CbGeAlD
Nilutamide—AR—cardiac atrium—kidney cancer	0.000885	0.0498	CbGeAlD
Nilutamide—CYP2C8—renal system—kidney cancer	0.000799	0.045	CbGeAlD
Nilutamide—CYP2C8—kidney—kidney cancer	0.000773	0.0435	CbGeAlD
Nilutamide—Gastrointestinal pain—Sorafenib—kidney cancer	0.000332	0.00104	CcSEcCtD
Nilutamide—Hypertension—Gemcitabine—kidney cancer	0.000332	0.00104	CcSEcCtD
Nilutamide—Pruritus—Everolimus—kidney cancer	0.000331	0.00104	CcSEcCtD
Nilutamide—Oedema—Vincristine—kidney cancer	0.000331	0.00104	CcSEcCtD
Nilutamide—Urinary tract infection—Capecitabine—kidney cancer	0.000329	0.00103	CcSEcCtD
Nilutamide—Chest pain—Gemcitabine—kidney cancer	0.000327	0.00103	CcSEcCtD
Nilutamide—Alopecia—Paclitaxel—kidney cancer	0.000327	0.00103	CcSEcCtD
Nilutamide—Blood alkaline phosphatase increased—Doxorubicin—kidney cancer	0.000325	0.00102	CcSEcCtD
Nilutamide—Asthenia—Erlotinib—kidney cancer	0.000324	0.00102	CcSEcCtD
Nilutamide—Discomfort—Gemcitabine—kidney cancer	0.000323	0.00102	CcSEcCtD
Nilutamide—Haematuria—Capecitabine—kidney cancer	0.000322	0.00101	CcSEcCtD
Nilutamide—Decreased appetite—Dactinomycin—kidney cancer	0.000322	0.00101	CcSEcCtD
Nilutamide—Diarrhoea—Vinblastine—kidney cancer	0.000322	0.00101	CcSEcCtD
Nilutamide—Body temperature increased—Sorafenib—kidney cancer	0.000321	0.00101	CcSEcCtD
Nilutamide—Abdominal pain—Sorafenib—kidney cancer	0.000321	0.00101	CcSEcCtD
Nilutamide—Diarrhoea—Everolimus—kidney cancer	0.00032	0.00101	CcSEcCtD
Nilutamide—Gastrointestinal pain—Sunitinib—kidney cancer	0.00032	0.001	CcSEcCtD
Nilutamide—Hyperhidrosis—Vincristine—kidney cancer	0.00032	0.001	CcSEcCtD
Nilutamide—Pruritus—Erlotinib—kidney cancer	0.00032	0.001	CcSEcCtD
Nilutamide—Pain—Dactinomycin—kidney cancer	0.000317	0.000994	CcSEcCtD
Nilutamide—Tension—Paclitaxel—kidney cancer	0.000316	0.000992	CcSEcCtD
Nilutamide—Anorexia—Vincristine—kidney cancer	0.000315	0.00099	CcSEcCtD
Nilutamide—Oedema—Gemcitabine—kidney cancer	0.000314	0.000985	CcSEcCtD
Nilutamide—Nervousness—Paclitaxel—kidney cancer	0.000313	0.000982	CcSEcCtD
Nilutamide—Back pain—Paclitaxel—kidney cancer	0.000311	0.000978	CcSEcCtD
Nilutamide—Dizziness—Vinblastine—kidney cancer	0.000311	0.000976	CcSEcCtD
Nilutamide—Dizziness—Everolimus—kidney cancer	0.00031	0.000972	CcSEcCtD
Nilutamide—Body temperature increased—Sunitinib—kidney cancer	0.000309	0.000971	CcSEcCtD
Nilutamide—Abdominal pain—Sunitinib—kidney cancer	0.000309	0.000971	CcSEcCtD
Nilutamide—Diarrhoea—Erlotinib—kidney cancer	0.000309	0.000971	CcSEcCtD
Nilutamide—Feeling abnormal—Dactinomycin—kidney cancer	0.000305	0.000958	CcSEcCtD
Nilutamide—Rhinitis—Capecitabine—kidney cancer	0.000304	0.000955	CcSEcCtD
Nilutamide—Hyperhidrosis—Gemcitabine—kidney cancer	0.000303	0.000953	CcSEcCtD
Nilutamide—Gastrointestinal pain—Dactinomycin—kidney cancer	0.000303	0.000951	CcSEcCtD
Nilutamide—Hot flush—Doxorubicin—kidney cancer	0.000302	0.000949	CcSEcCtD
Nilutamide—Hypoaesthesia—Capecitabine—kidney cancer	0.000302	0.000948	CcSEcCtD
Nilutamide—Urinary tract disorder—Capecitabine—kidney cancer	0.0003	0.000941	CcSEcCtD
Nilutamide—Menopausal symptoms—Doxorubicin—kidney cancer	0.0003	0.000941	CcSEcCtD
Nilutamide—Insomnia—Vincristine—kidney cancer	0.000299	0.000939	CcSEcCtD
Nilutamide—Anorexia—Gemcitabine—kidney cancer	0.000299	0.000939	CcSEcCtD
Nilutamide—Oedema peripheral—Capecitabine—kidney cancer	0.000299	0.000939	CcSEcCtD
Nilutamide—Vomiting—Vinblastine—kidney cancer	0.000299	0.000938	CcSEcCtD
Nilutamide—Dizziness—Erlotinib—kidney cancer	0.000299	0.000938	CcSEcCtD
Nilutamide—Ill-defined disorder—Paclitaxel—kidney cancer	0.000299	0.000938	CcSEcCtD
Nilutamide—Vomiting—Everolimus—kidney cancer	0.000298	0.000935	CcSEcCtD
Nilutamide—Anaemia—Paclitaxel—kidney cancer	0.000298	0.000934	CcSEcCtD
Nilutamide—Urethral disorder—Capecitabine—kidney cancer	0.000298	0.000934	CcSEcCtD
Nilutamide—Paraesthesia—Vincristine—kidney cancer	0.000297	0.000933	CcSEcCtD
Nilutamide—Rash—Everolimus—kidney cancer	0.000295	0.000927	CcSEcCtD
Nilutamide—Dermatitis—Everolimus—kidney cancer	0.000295	0.000926	CcSEcCtD
Nilutamide—Headache—Vinblastine—kidney cancer	0.000295	0.000925	CcSEcCtD
Nilutamide—Headache—Everolimus—kidney cancer	0.000293	0.000921	CcSEcCtD
Nilutamide—Abdominal pain—Dactinomycin—kidney cancer	0.000293	0.000919	CcSEcCtD
Nilutamide—Body temperature increased—Dactinomycin—kidney cancer	0.000293	0.000919	CcSEcCtD
Nilutamide—Visual impairment—Capecitabine—kidney cancer	0.000293	0.000918	CcSEcCtD
Nilutamide—Asthenia—Sorafenib—kidney cancer	0.000292	0.000916	CcSEcCtD
Nilutamide—Malaise—Paclitaxel—kidney cancer	0.00029	0.000912	CcSEcCtD
Nilutamide—Cardiac failure—Doxorubicin—kidney cancer	0.00029	0.00091	CcSEcCtD
Nilutamide—Syncope—Paclitaxel—kidney cancer	0.000289	0.000906	CcSEcCtD
Nilutamide—Leukopenia—Paclitaxel—kidney cancer	0.000288	0.000905	CcSEcCtD
Nilutamide—Decreased appetite—Vincristine—kidney cancer	0.000288	0.000903	CcSEcCtD
Nilutamide—Pruritus—Sorafenib—kidney cancer	0.000288	0.000903	CcSEcCtD
Nilutamide—Vomiting—Erlotinib—kidney cancer	0.000287	0.000902	CcSEcCtD
Nilutamide—Gastrointestinal disorder—Vincristine—kidney cancer	0.000286	0.000897	CcSEcCtD
Nilutamide—Rash—Erlotinib—kidney cancer	0.000285	0.000894	CcSEcCtD
Nilutamide—Dermatitis—Erlotinib—kidney cancer	0.000285	0.000894	CcSEcCtD
Nilutamide—Insomnia—Gemcitabine—kidney cancer	0.000284	0.000891	CcSEcCtD
Nilutamide—Headache—Erlotinib—kidney cancer	0.000283	0.000889	CcSEcCtD
Nilutamide—Loss of consciousness—Paclitaxel—kidney cancer	0.000283	0.000888	CcSEcCtD
Nilutamide—Constipation—Vincristine—kidney cancer	0.000283	0.000888	CcSEcCtD
Nilutamide—Pain—Vincristine—kidney cancer	0.000283	0.000888	CcSEcCtD
Nilutamide—Gastrointestinal haemorrhage—Doxorubicin—kidney cancer	0.000283	0.000888	CcSEcCtD
Nilutamide—Paraesthesia—Gemcitabine—kidney cancer	0.000282	0.000885	CcSEcCtD
Nilutamide—Cough—Paclitaxel—kidney cancer	0.000281	0.000882	CcSEcCtD
Nilutamide—Asthenia—Sunitinib—kidney cancer	0.000281	0.000881	CcSEcCtD
Nilutamide—Dyspnoea—Gemcitabine—kidney cancer	0.00028	0.000878	CcSEcCtD
Nilutamide—Nausea—Vinblastine—kidney cancer	0.000279	0.000877	CcSEcCtD
Nilutamide—Nausea—Everolimus—kidney cancer	0.000278	0.000873	CcSEcCtD
Nilutamide—Diarrhoea—Sorafenib—kidney cancer	0.000278	0.000873	CcSEcCtD
Nilutamide—Hypertension—Paclitaxel—kidney cancer	0.000278	0.000873	CcSEcCtD
Nilutamide—Pruritus—Sunitinib—kidney cancer	0.000277	0.000869	CcSEcCtD
Nilutamide—Chest pain—Paclitaxel—kidney cancer	0.000274	0.000861	CcSEcCtD
Nilutamide—Decreased appetite—Gemcitabine—kidney cancer	0.000273	0.000857	CcSEcCtD
Nilutamide—Gastrointestinal disorder—Gemcitabine—kidney cancer	0.000271	0.000851	CcSEcCtD
Nilutamide—Discomfort—Paclitaxel—kidney cancer	0.000271	0.00085	CcSEcCtD
Nilutamide—Gastrointestinal pain—Vincristine—kidney cancer	0.000271	0.000849	CcSEcCtD
Nilutamide—Dizziness—Sorafenib—kidney cancer	0.000269	0.000844	CcSEcCtD
Nilutamide—Pain—Gemcitabine—kidney cancer	0.000268	0.000843	CcSEcCtD
Nilutamide—Constipation—Gemcitabine—kidney cancer	0.000268	0.000843	CcSEcCtD
Nilutamide—Nausea—Erlotinib—kidney cancer	0.000268	0.000843	CcSEcCtD
Nilutamide—Alopecia—Capecitabine—kidney cancer	0.000268	0.000842	CcSEcCtD
Nilutamide—Dry mouth—Paclitaxel—kidney cancer	0.000268	0.000842	CcSEcCtD
Nilutamide—Diarrhoea—Sunitinib—kidney cancer	0.000268	0.00084	CcSEcCtD
Nilutamide—Asthenia—Dactinomycin—kidney cancer	0.000266	0.000834	CcSEcCtD
Nilutamide—Blood creatinine increased—Doxorubicin—kidney cancer	0.000265	0.000832	CcSEcCtD
Nilutamide—Oedema—Paclitaxel—kidney cancer	0.000263	0.000825	CcSEcCtD
Nilutamide—Abdominal pain—Vincristine—kidney cancer	0.000262	0.000821	CcSEcCtD
Nilutamide—Body temperature increased—Vincristine—kidney cancer	0.000262	0.000821	CcSEcCtD
Nilutamide—Dry skin—Doxorubicin—kidney cancer	0.000259	0.000814	CcSEcCtD
Nilutamide—Dizziness—Sunitinib—kidney cancer	0.000259	0.000812	CcSEcCtD
Nilutamide—Feeling abnormal—Gemcitabine—kidney cancer	0.000259	0.000812	CcSEcCtD
Nilutamide—Shock—Paclitaxel—kidney cancer	0.000259	0.000812	CcSEcCtD
Nilutamide—Vomiting—Sorafenib—kidney cancer	0.000258	0.000811	CcSEcCtD
Nilutamide—Rash—Sorafenib—kidney cancer	0.000256	0.000805	CcSEcCtD
Nilutamide—Dermatitis—Sorafenib—kidney cancer	0.000256	0.000804	CcSEcCtD
Nilutamide—Back pain—Capecitabine—kidney cancer	0.000256	0.000802	CcSEcCtD
Nilutamide—Aspartate aminotransferase increased—Doxorubicin—kidney cancer	0.000255	0.0008	CcSEcCtD
Nilutamide—Headache—Sorafenib—kidney cancer	0.000255	0.000799	CcSEcCtD
Nilutamide—Hyperhidrosis—Paclitaxel—kidney cancer	0.000254	0.000798	CcSEcCtD
Nilutamide—Diarrhoea—Dactinomycin—kidney cancer	0.000253	0.000795	CcSEcCtD
Nilutamide—Anorexia—Paclitaxel—kidney cancer	0.00025	0.000786	CcSEcCtD
Nilutamide—Alanine aminotransferase increased—Doxorubicin—kidney cancer	0.000249	0.000783	CcSEcCtD
Nilutamide—Vomiting—Sunitinib—kidney cancer	0.000249	0.000781	CcSEcCtD
Nilutamide—Body temperature increased—Gemcitabine—kidney cancer	0.000248	0.000779	CcSEcCtD
Nilutamide—Rash—Sunitinib—kidney cancer	0.000247	0.000774	CcSEcCtD
Nilutamide—Dermatitis—Sunitinib—kidney cancer	0.000246	0.000774	CcSEcCtD
Nilutamide—Ill-defined disorder—Capecitabine—kidney cancer	0.000245	0.00077	CcSEcCtD
Nilutamide—Headache—Sunitinib—kidney cancer	0.000245	0.000769	CcSEcCtD
Nilutamide—Influenza—Doxorubicin—kidney cancer	0.000244	0.000767	CcSEcCtD
Nilutamide—Anaemia—Capecitabine—kidney cancer	0.000244	0.000767	CcSEcCtD
Nilutamide—Nausea—Sorafenib—kidney cancer	0.000241	0.000758	CcSEcCtD
Nilutamide—Malaise—Capecitabine—kidney cancer	0.000238	0.000748	CcSEcCtD
Nilutamide—Angina pectoris—Doxorubicin—kidney cancer	0.000238	0.000748	CcSEcCtD
Nilutamide—Insomnia—Paclitaxel—kidney cancer	0.000238	0.000746	CcSEcCtD
Nilutamide—Asthenia—Vincristine—kidney cancer	0.000237	0.000745	CcSEcCtD
Nilutamide—Syncope—Capecitabine—kidney cancer	0.000237	0.000744	CcSEcCtD
Nilutamide—Leukopenia—Capecitabine—kidney cancer	0.000237	0.000743	CcSEcCtD
Nilutamide—Paraesthesia—Paclitaxel—kidney cancer	0.000236	0.000741	CcSEcCtD
Nilutamide—Vomiting—Dactinomycin—kidney cancer	0.000235	0.000739	CcSEcCtD
Nilutamide—Dyspnoea—Paclitaxel—kidney cancer	0.000234	0.000735	CcSEcCtD
Nilutamide—Rash—Dactinomycin—kidney cancer	0.000233	0.000733	CcSEcCtD
Nilutamide—Nausea—Sunitinib—kidney cancer	0.000232	0.000729	CcSEcCtD
Nilutamide—Loss of consciousness—Capecitabine—kidney cancer	0.000232	0.000729	CcSEcCtD
Nilutamide—Dyspepsia—Paclitaxel—kidney cancer	0.000231	0.000726	CcSEcCtD
Nilutamide—Cough—Capecitabine—kidney cancer	0.000231	0.000724	CcSEcCtD
Nilutamide—Decreased appetite—Paclitaxel—kidney cancer	0.000228	0.000717	CcSEcCtD
Nilutamide—Hypertension—Capecitabine—kidney cancer	0.000228	0.000716	CcSEcCtD
Nilutamide—Upper respiratory tract infection—Doxorubicin—kidney cancer	0.000227	0.000713	CcSEcCtD
Nilutamide—Gastrointestinal disorder—Paclitaxel—kidney cancer	0.000227	0.000712	CcSEcCtD
Nilutamide—Diarrhoea—Vincristine—kidney cancer	0.000226	0.000711	CcSEcCtD
Nilutamide—Asthenia—Gemcitabine—kidney cancer	0.000225	0.000707	CcSEcCtD
Nilutamide—Chest pain—Capecitabine—kidney cancer	0.000225	0.000706	CcSEcCtD
Nilutamide—Pain—Paclitaxel—kidney cancer	0.000225	0.000705	CcSEcCtD
Nilutamide—Constipation—Paclitaxel—kidney cancer	0.000225	0.000705	CcSEcCtD
Nilutamide—Discomfort—Capecitabine—kidney cancer	0.000222	0.000698	CcSEcCtD
Nilutamide—Pruritus—Gemcitabine—kidney cancer	0.000222	0.000697	CcSEcCtD
Nilutamide—Weight decreased—Doxorubicin—kidney cancer	0.000221	0.000694	CcSEcCtD
Nilutamide—Hyperglycaemia—Doxorubicin—kidney cancer	0.000221	0.000692	CcSEcCtD
Nilutamide—Dry mouth—Capecitabine—kidney cancer	0.00022	0.000691	CcSEcCtD
Nilutamide—Nausea—Dactinomycin—kidney cancer	0.00022	0.000691	CcSEcCtD
Nilutamide—Pneumonia—Doxorubicin—kidney cancer	0.000219	0.000688	CcSEcCtD
Nilutamide—Dizziness—Vincristine—kidney cancer	0.000219	0.000687	CcSEcCtD
Nilutamide—Feeling abnormal—Paclitaxel—kidney cancer	0.000217	0.00068	CcSEcCtD
Nilutamide—Oedema—Capecitabine—kidney cancer	0.000216	0.000677	CcSEcCtD
Nilutamide—Gastrointestinal pain—Paclitaxel—kidney cancer	0.000215	0.000675	CcSEcCtD
Nilutamide—Diarrhoea—Gemcitabine—kidney cancer	0.000215	0.000674	CcSEcCtD
Nilutamide—Shock—Capecitabine—kidney cancer	0.000212	0.000666	CcSEcCtD
Nilutamide—Urinary tract infection—Doxorubicin—kidney cancer	0.000212	0.000665	CcSEcCtD
Nilutamide—Vomiting—Vincristine—kidney cancer	0.00021	0.00066	CcSEcCtD
Nilutamide—Sweating—Doxorubicin—kidney cancer	0.000209	0.000656	CcSEcCtD
Nilutamide—Rash—Vincristine—kidney cancer	0.000209	0.000655	CcSEcCtD
Nilutamide—Hyperhidrosis—Capecitabine—kidney cancer	0.000208	0.000654	CcSEcCtD
Nilutamide—Dermatitis—Vincristine—kidney cancer	0.000208	0.000654	CcSEcCtD
Nilutamide—Haematuria—Doxorubicin—kidney cancer	0.000208	0.000652	CcSEcCtD
Nilutamide—Abdominal pain—Paclitaxel—kidney cancer	0.000208	0.000652	CcSEcCtD
Nilutamide—Body temperature increased—Paclitaxel—kidney cancer	0.000208	0.000652	CcSEcCtD
Nilutamide—Headache—Vincristine—kidney cancer	0.000207	0.000651	CcSEcCtD
Nilutamide—Anorexia—Capecitabine—kidney cancer	0.000206	0.000645	CcSEcCtD
Nilutamide—Vomiting—Gemcitabine—kidney cancer	0.0002	0.000626	CcSEcCtD
Nilutamide—Rash—Gemcitabine—kidney cancer	0.000198	0.000621	CcSEcCtD
Nilutamide—Dermatitis—Gemcitabine—kidney cancer	0.000198	0.000621	CcSEcCtD
Nilutamide—Headache—Gemcitabine—kidney cancer	0.000197	0.000617	CcSEcCtD
Nilutamide—Nausea—Vincristine—kidney cancer	0.000197	0.000617	CcSEcCtD
Nilutamide—Rhinitis—Doxorubicin—kidney cancer	0.000196	0.000616	CcSEcCtD
Nilutamide—Insomnia—Capecitabine—kidney cancer	0.000195	0.000612	CcSEcCtD
Nilutamide—Hypoaesthesia—Doxorubicin—kidney cancer	0.000195	0.000611	CcSEcCtD
Nilutamide—Paraesthesia—Capecitabine—kidney cancer	0.000194	0.000608	CcSEcCtD
Nilutamide—Urinary tract disorder—Doxorubicin—kidney cancer	0.000193	0.000607	CcSEcCtD
Nilutamide—Oedema peripheral—Doxorubicin—kidney cancer	0.000193	0.000605	CcSEcCtD
Nilutamide—Dyspnoea—Capecitabine—kidney cancer	0.000192	0.000604	CcSEcCtD
Nilutamide—Urethral disorder—Doxorubicin—kidney cancer	0.000192	0.000602	CcSEcCtD
Nilutamide—Dyspepsia—Capecitabine—kidney cancer	0.00019	0.000596	CcSEcCtD
Nilutamide—Visual impairment—Doxorubicin—kidney cancer	0.000189	0.000592	CcSEcCtD
Nilutamide—Asthenia—Paclitaxel—kidney cancer	0.000189	0.000592	CcSEcCtD
Nilutamide—Decreased appetite—Capecitabine—kidney cancer	0.000187	0.000589	CcSEcCtD
Nilutamide—Nausea—Gemcitabine—kidney cancer	0.000186	0.000585	CcSEcCtD
Nilutamide—Gastrointestinal disorder—Capecitabine—kidney cancer	0.000186	0.000584	CcSEcCtD
Nilutamide—Pruritus—Paclitaxel—kidney cancer	0.000186	0.000584	CcSEcCtD
Nilutamide—Constipation—Capecitabine—kidney cancer	0.000184	0.000579	CcSEcCtD
Nilutamide—Pain—Capecitabine—kidney cancer	0.000184	0.000579	CcSEcCtD
Nilutamide—Diarrhoea—Paclitaxel—kidney cancer	0.00018	0.000564	CcSEcCtD
Nilutamide—Feeling abnormal—Capecitabine—kidney cancer	0.000178	0.000558	CcSEcCtD
Nilutamide—Gastrointestinal pain—Capecitabine—kidney cancer	0.000176	0.000554	CcSEcCtD
Nilutamide—Dizziness—Paclitaxel—kidney cancer	0.000174	0.000546	CcSEcCtD
Nilutamide—Alopecia—Doxorubicin—kidney cancer	0.000173	0.000543	CcSEcCtD
Nilutamide—Abdominal pain—Capecitabine—kidney cancer	0.00017	0.000535	CcSEcCtD
Nilutamide—Body temperature increased—Capecitabine—kidney cancer	0.00017	0.000535	CcSEcCtD
Nilutamide—Tension—Doxorubicin—kidney cancer	0.000167	0.000525	CcSEcCtD
Nilutamide—Vomiting—Paclitaxel—kidney cancer	0.000167	0.000525	CcSEcCtD
Nilutamide—Rash—Paclitaxel—kidney cancer	0.000166	0.00052	CcSEcCtD
Nilutamide—Dermatitis—Paclitaxel—kidney cancer	0.000166	0.00052	CcSEcCtD
Nilutamide—Nervousness—Doxorubicin—kidney cancer	0.000165	0.000519	CcSEcCtD
Nilutamide—Back pain—Doxorubicin—kidney cancer	0.000165	0.000517	CcSEcCtD
Nilutamide—Headache—Paclitaxel—kidney cancer	0.000165	0.000517	CcSEcCtD
Nilutamide—Ill-defined disorder—Doxorubicin—kidney cancer	0.000158	0.000496	CcSEcCtD
Nilutamide—Anaemia—Doxorubicin—kidney cancer	0.000157	0.000494	CcSEcCtD
Nilutamide—Nausea—Paclitaxel—kidney cancer	0.000156	0.00049	CcSEcCtD
Nilutamide—Asthenia—Capecitabine—kidney cancer	0.000155	0.000486	CcSEcCtD
Nilutamide—Malaise—Doxorubicin—kidney cancer	0.000154	0.000482	CcSEcCtD
Nilutamide—Syncope—Doxorubicin—kidney cancer	0.000153	0.00048	CcSEcCtD
Nilutamide—Pruritus—Capecitabine—kidney cancer	0.000153	0.000479	CcSEcCtD
Nilutamide—Leukopenia—Doxorubicin—kidney cancer	0.000152	0.000479	CcSEcCtD
Nilutamide—Loss of consciousness—Doxorubicin—kidney cancer	0.00015	0.00047	CcSEcCtD
Nilutamide—Cough—Doxorubicin—kidney cancer	0.000149	0.000467	CcSEcCtD
Nilutamide—Diarrhoea—Capecitabine—kidney cancer	0.000148	0.000463	CcSEcCtD
Nilutamide—Hypertension—Doxorubicin—kidney cancer	0.000147	0.000462	CcSEcCtD
Nilutamide—Chest pain—Doxorubicin—kidney cancer	0.000145	0.000455	CcSEcCtD
Nilutamide—Discomfort—Doxorubicin—kidney cancer	0.000143	0.00045	CcSEcCtD
Nilutamide—Dizziness—Capecitabine—kidney cancer	0.000143	0.000448	CcSEcCtD
Nilutamide—Dry mouth—Doxorubicin—kidney cancer	0.000142	0.000445	CcSEcCtD
Nilutamide—Oedema—Doxorubicin—kidney cancer	0.000139	0.000436	CcSEcCtD
Nilutamide—Vomiting—Capecitabine—kidney cancer	0.000137	0.00043	CcSEcCtD
Nilutamide—Shock—Doxorubicin—kidney cancer	0.000137	0.000429	CcSEcCtD
Nilutamide—Rash—Capecitabine—kidney cancer	0.000136	0.000427	CcSEcCtD
Nilutamide—Dermatitis—Capecitabine—kidney cancer	0.000136	0.000426	CcSEcCtD
Nilutamide—Headache—Capecitabine—kidney cancer	0.000135	0.000424	CcSEcCtD
Nilutamide—Hyperhidrosis—Doxorubicin—kidney cancer	0.000134	0.000422	CcSEcCtD
Nilutamide—Anorexia—Doxorubicin—kidney cancer	0.000133	0.000416	CcSEcCtD
Nilutamide—Nausea—Capecitabine—kidney cancer	0.000128	0.000402	CcSEcCtD
Nilutamide—Insomnia—Doxorubicin—kidney cancer	0.000126	0.000395	CcSEcCtD
Nilutamide—Paraesthesia—Doxorubicin—kidney cancer	0.000125	0.000392	CcSEcCtD
Nilutamide—Dyspnoea—Doxorubicin—kidney cancer	0.000124	0.000389	CcSEcCtD
Nilutamide—Dyspepsia—Doxorubicin—kidney cancer	0.000122	0.000384	CcSEcCtD
Nilutamide—Decreased appetite—Doxorubicin—kidney cancer	0.000121	0.000379	CcSEcCtD
Nilutamide—Gastrointestinal disorder—Doxorubicin—kidney cancer	0.00012	0.000377	CcSEcCtD
Nilutamide—Pain—Doxorubicin—kidney cancer	0.000119	0.000373	CcSEcCtD
Nilutamide—Constipation—Doxorubicin—kidney cancer	0.000119	0.000373	CcSEcCtD
Nilutamide—Feeling abnormal—Doxorubicin—kidney cancer	0.000115	0.00036	CcSEcCtD
Nilutamide—Gastrointestinal pain—Doxorubicin—kidney cancer	0.000114	0.000357	CcSEcCtD
Nilutamide—Body temperature increased—Doxorubicin—kidney cancer	0.00011	0.000345	CcSEcCtD
Nilutamide—Abdominal pain—Doxorubicin—kidney cancer	0.00011	0.000345	CcSEcCtD
Nilutamide—Asthenia—Doxorubicin—kidney cancer	9.97e-05	0.000313	CcSEcCtD
Nilutamide—Pruritus—Doxorubicin—kidney cancer	9.83e-05	0.000309	CcSEcCtD
Nilutamide—Diarrhoea—Doxorubicin—kidney cancer	9.51e-05	0.000299	CcSEcCtD
Nilutamide—Dizziness—Doxorubicin—kidney cancer	9.19e-05	0.000289	CcSEcCtD
Nilutamide—Vomiting—Doxorubicin—kidney cancer	8.84e-05	0.000277	CcSEcCtD
Nilutamide—Rash—Doxorubicin—kidney cancer	8.76e-05	0.000275	CcSEcCtD
Nilutamide—Dermatitis—Doxorubicin—kidney cancer	8.76e-05	0.000275	CcSEcCtD
Nilutamide—Headache—Doxorubicin—kidney cancer	8.71e-05	0.000273	CcSEcCtD
Nilutamide—AR—Integrated Pancreatic Cancer Pathway—EGR1—kidney cancer	8.62e-05	0.00428	CbGpPWpGaD
Nilutamide—AR—Regulation of nuclear beta catenin signaling and target gene transcription—CDKN2A—kidney cancer	8.6e-05	0.00427	CbGpPWpGaD
Nilutamide—AR—Gene Expression—HARS—kidney cancer	8.29e-05	0.00412	CbGpPWpGaD
Nilutamide—Nausea—Doxorubicin—kidney cancer	8.26e-05	0.000259	CcSEcCtD
Nilutamide—CYP2C19—Arachidonic acid metabolism—CYP1A1—kidney cancer	8.23e-05	0.00409	CbGpPWpGaD
Nilutamide—CYP2C9—Phase 1 - Functionalization of compounds—PTGS1—kidney cancer	8.15e-05	0.00405	CbGpPWpGaD
Nilutamide—CYP2C8—Cytochrome P450 - arranged by substrate type—CYP1A1—kidney cancer	7.96e-05	0.00396	CbGpPWpGaD
Nilutamide—CYP2C9—Biological oxidations—ALDH1A1—kidney cancer	7.87e-05	0.00391	CbGpPWpGaD
Nilutamide—CYP2C8—Oxidation by Cytochrome P450—CYP1A1—kidney cancer	7.86e-05	0.0039	CbGpPWpGaD
Nilutamide—AR—Androgen receptor signaling pathway—RELA—kidney cancer	7.6e-05	0.00378	CbGpPWpGaD
Nilutamide—AR—Integrated Pancreatic Cancer Pathway—BRCA2—kidney cancer	7.56e-05	0.00376	CbGpPWpGaD
Nilutamide—CYP2C9—Arachidonic acid metabolism—CYP1A1—kidney cancer	7.5e-05	0.00373	CbGpPWpGaD
Nilutamide—AR—Integrated Pancreatic Cancer Pathway—CDKN2B—kidney cancer	7.5e-05	0.00372	CbGpPWpGaD
Nilutamide—AR—Integrated Pancreatic Cancer Pathway—ABCB1—kidney cancer	7.33e-05	0.00364	CbGpPWpGaD
Nilutamide—AR—Regulation of nuclear beta catenin signaling and target gene transcription—CCND1—kidney cancer	7.27e-05	0.00361	CbGpPWpGaD
Nilutamide—AR—Regulation of nuclear beta catenin signaling and target gene transcription—JUN—kidney cancer	7.25e-05	0.0036	CbGpPWpGaD
Nilutamide—AR—Integrated Breast Cancer Pathway—TSC2—kidney cancer	7.22e-05	0.00358	CbGpPWpGaD
Nilutamide—AR—Regulation of nuclear beta catenin signaling and target gene transcription—CTNNB1—kidney cancer	7.2e-05	0.00358	CbGpPWpGaD
Nilutamide—AR—Regulation of nuclear SMAD2/3 signaling—JUN—kidney cancer	7.18e-05	0.00357	CbGpPWpGaD
Nilutamide—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP1A1—kidney cancer	7.11e-05	0.00353	CbGpPWpGaD
Nilutamide—AR—Gene Expression—EIF5B—kidney cancer	7.05e-05	0.0035	CbGpPWpGaD
Nilutamide—AR—SIDS Susceptibility Pathways—HIF1A—kidney cancer	7.05e-05	0.0035	CbGpPWpGaD
Nilutamide—CYP2C19—Oxidation by Cytochrome P450—CYP1A1—kidney cancer	7.02e-05	0.00349	CbGpPWpGaD
Nilutamide—AR—Androgen receptor signaling pathway—CCND1—kidney cancer	6.67e-05	0.00332	CbGpPWpGaD
Nilutamide—AR—Androgen receptor signaling pathway—JUN—kidney cancer	6.66e-05	0.00331	CbGpPWpGaD
Nilutamide—AR—Androgen receptor signaling pathway—CTNNB1—kidney cancer	6.61e-05	0.00328	CbGpPWpGaD
Nilutamide—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP1A1—kidney cancer	6.48e-05	0.00322	CbGpPWpGaD
Nilutamide—CYP2C8—Phase 1 - Functionalization of compounds—CYP1A1—kidney cancer	6.46e-05	0.00321	CbGpPWpGaD
Nilutamide—AR—Androgen receptor signaling pathway—PTEN—kidney cancer	6.44e-05	0.0032	CbGpPWpGaD
Nilutamide—CYP2C9—Oxidation by Cytochrome P450—CYP1A1—kidney cancer	6.4e-05	0.00318	CbGpPWpGaD
Nilutamide—AR—Integrated Breast Cancer Pathway—BRAF—kidney cancer	5.99e-05	0.00298	CbGpPWpGaD
Nilutamide—CYP2C8—Cytochrome P450 - arranged by substrate type—POMC—kidney cancer	5.94e-05	0.00295	CbGpPWpGaD
Nilutamide—AR—Integrated Breast Cancer Pathway—CDH1—kidney cancer	5.86e-05	0.00291	CbGpPWpGaD
Nilutamide—AR—Regulation of nuclear beta catenin signaling and target gene transcription—MYC—kidney cancer	5.83e-05	0.0029	CbGpPWpGaD
Nilutamide—AR—Regulation of nuclear SMAD2/3 signaling—MYC—kidney cancer	5.77e-05	0.00287	CbGpPWpGaD
Nilutamide—CYP2C19—Phase 1 - Functionalization of compounds—CYP1A1—kidney cancer	5.76e-05	0.00286	CbGpPWpGaD
Nilutamide—CYP2C8—Biological oxidations—GSTT1—kidney cancer	5.68e-05	0.00282	CbGpPWpGaD
Nilutamide—CYP2C8—Arachidonic acid metabolism—PTGS2—kidney cancer	5.48e-05	0.00272	CbGpPWpGaD
Nilutamide—CYP2C8—Biological oxidations—PTGS1—kidney cancer	5.32e-05	0.00264	CbGpPWpGaD
Nilutamide—CYP2C19—Cytochrome P450 - arranged by substrate type—POMC—kidney cancer	5.3e-05	0.00263	CbGpPWpGaD
Nilutamide—AR—Integrated Pancreatic Cancer Pathway—APC—kidney cancer	5.28e-05	0.00262	CbGpPWpGaD
Nilutamide—CYP2C9—Phase 1 - Functionalization of compounds—CYP1A1—kidney cancer	5.25e-05	0.00261	CbGpPWpGaD
Nilutamide—CYP2C19—Biological oxidations—GSTT1—kidney cancer	5.07e-05	0.00252	CbGpPWpGaD
Nilutamide—CYP2C19—Arachidonic acid metabolism—PTGS2—kidney cancer	4.89e-05	0.00243	CbGpPWpGaD
Nilutamide—AR—Integrated Breast Cancer Pathway—MTOR—kidney cancer	4.88e-05	0.00243	CbGpPWpGaD
Nilutamide—CYP2C9—Cytochrome P450 - arranged by substrate type—POMC—kidney cancer	4.83e-05	0.0024	CbGpPWpGaD
Nilutamide—CYP2C8—Phase 1 - Functionalization of compounds—POMC—kidney cancer	4.81e-05	0.00239	CbGpPWpGaD
Nilutamide—CYP2C19—Biological oxidations—PTGS1—kidney cancer	4.75e-05	0.00236	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism of lipids and lipoproteins—GLIPR1—kidney cancer	4.7e-05	0.00233	CbGpPWpGaD
Nilutamide—CYP2C9—Biological oxidations—GSTT1—kidney cancer	4.62e-05	0.0023	CbGpPWpGaD
Nilutamide—AR—Generic Transcription Pathway—JUNB—kidney cancer	4.58e-05	0.00227	CbGpPWpGaD
Nilutamide—AR—Gene Expression—EEF2—kidney cancer	4.54e-05	0.00226	CbGpPWpGaD
Nilutamide—CYP2C9—Arachidonic acid metabolism—PTGS2—kidney cancer	4.46e-05	0.00222	CbGpPWpGaD
Nilutamide—AR—Integrated Breast Cancer Pathway—CCND1—kidney cancer	4.37e-05	0.00217	CbGpPWpGaD
Nilutamide—AR—Integrated Breast Cancer Pathway—JUN—kidney cancer	4.36e-05	0.00217	CbGpPWpGaD
Nilutamide—AR—Gene Expression—TET2—kidney cancer	4.36e-05	0.00216	CbGpPWpGaD
Nilutamide—CYP2C9—Biological oxidations—PTGS1—kidney cancer	4.33e-05	0.00215	CbGpPWpGaD
Nilutamide—AR—Integrated Breast Cancer Pathway—CTNNB1—kidney cancer	4.33e-05	0.00215	CbGpPWpGaD
Nilutamide—CYP2C19—Phase 1 - Functionalization of compounds—POMC—kidney cancer	4.3e-05	0.00213	CbGpPWpGaD
Nilutamide—AR—SIDS Susceptibility Pathways—JUN—kidney cancer	4.25e-05	0.00211	CbGpPWpGaD
Nilutamide—AR—Integrated Breast Cancer Pathway—PTEN—kidney cancer	4.22e-05	0.0021	CbGpPWpGaD
Nilutamide—AR—SIDS Susceptibility Pathways—CTNNB1—kidney cancer	4.22e-05	0.0021	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism of lipids and lipoproteins—GLIPR1—kidney cancer	4.19e-05	0.00208	CbGpPWpGaD
Nilutamide—AR—Integrated Pancreatic Cancer Pathway—RAF1—kidney cancer	4.14e-05	0.00206	CbGpPWpGaD
Nilutamide—AR—Integrated Pancreatic Cancer Pathway—ERBB2—kidney cancer	4.1e-05	0.00204	CbGpPWpGaD
Nilutamide—AR—Integrated Pancreatic Cancer Pathway—PTGS2—kidney cancer	4.01e-05	0.00199	CbGpPWpGaD
Nilutamide—AR—Gene Expression—TCEB1—kidney cancer	3.98e-05	0.00198	CbGpPWpGaD
Nilutamide—AR—Gene Expression—TCEB2—kidney cancer	3.98e-05	0.00198	CbGpPWpGaD
Nilutamide—CYP2C8—Biological oxidations—GSTP1—kidney cancer	3.94e-05	0.00196	CbGpPWpGaD
Nilutamide—CYP2C9—Phase 1 - Functionalization of compounds—POMC—kidney cancer	3.92e-05	0.00195	CbGpPWpGaD
Nilutamide—CYP2C8—Metapathway biotransformation—GSTP1—kidney cancer	3.88e-05	0.00193	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism of lipids and lipoproteins—GLIPR1—kidney cancer	3.82e-05	0.0019	CbGpPWpGaD
Nilutamide—AR—Integrated Breast Cancer Pathway—VEGFA—kidney cancer	3.81e-05	0.00189	CbGpPWpGaD
Nilutamide—AR—Integrated Pancreatic Cancer Pathway—CDKN1B—kidney cancer	3.8e-05	0.00189	CbGpPWpGaD
Nilutamide—AR—Generic Transcription Pathway—CDKN2B—kidney cancer	3.72e-05	0.00185	CbGpPWpGaD
Nilutamide—AR—SIDS Susceptibility Pathways—VEGFA—kidney cancer	3.71e-05	0.00184	CbGpPWpGaD
Nilutamide—AR—Integrated Pancreatic Cancer Pathway—CCND1—kidney cancer	3.62e-05	0.0018	CbGpPWpGaD
Nilutamide—CYP2C8—Biological oxidations—GSTM1—kidney cancer	3.62e-05	0.0018	CbGpPWpGaD
Nilutamide—AR—Integrated Pancreatic Cancer Pathway—JUN—kidney cancer	3.61e-05	0.0018	CbGpPWpGaD
Nilutamide—AR—Integrated Pancreatic Cancer Pathway—CTNNB1—kidney cancer	3.59e-05	0.00178	CbGpPWpGaD
Nilutamide—CYP2C8—Metapathway biotransformation—GSTM1—kidney cancer	3.57e-05	0.00177	CbGpPWpGaD
Nilutamide—CYP2C19—Biological oxidations—GSTP1—kidney cancer	3.51e-05	0.00175	CbGpPWpGaD
Nilutamide—AR—Integrated Breast Cancer Pathway—MYC—kidney cancer	3.51e-05	0.00174	CbGpPWpGaD
Nilutamide—AR—Integrated Pancreatic Cancer Pathway—PTEN—kidney cancer	3.5e-05	0.00174	CbGpPWpGaD
Nilutamide—CYP2C19—Metapathway biotransformation—GSTP1—kidney cancer	3.47e-05	0.00172	CbGpPWpGaD
Nilutamide—AR—Integrated Breast Cancer Pathway—MAPK1—kidney cancer	3.43e-05	0.0017	CbGpPWpGaD
Nilutamide—CYP2C8—Biological oxidations—CYP1A1—kidney cancer	3.43e-05	0.0017	CbGpPWpGaD
Nilutamide—CYP2C8—Metapathway biotransformation—CYP1A1—kidney cancer	3.38e-05	0.00168	CbGpPWpGaD
Nilutamide—AR—Integrated Breast Cancer Pathway—KRAS—kidney cancer	3.24e-05	0.00161	CbGpPWpGaD
Nilutamide—AR—Gene Expression—RPL14—kidney cancer	3.24e-05	0.00161	CbGpPWpGaD
Nilutamide—CYP2C19—Biological oxidations—GSTM1—kidney cancer	3.23e-05	0.0016	CbGpPWpGaD
Nilutamide—CYP2C9—Biological oxidations—GSTP1—kidney cancer	3.2e-05	0.00159	CbGpPWpGaD
Nilutamide—CYP2C19—Metapathway biotransformation—GSTM1—kidney cancer	3.18e-05	0.00158	CbGpPWpGaD
Nilutamide—CYP2C9—Metapathway biotransformation—GSTP1—kidney cancer	3.16e-05	0.00157	CbGpPWpGaD
Nilutamide—AR—Integrated Pancreatic Cancer Pathway—VEGFA—kidney cancer	3.16e-05	0.00157	CbGpPWpGaD
Nilutamide—CYP2C19—Biological oxidations—CYP1A1—kidney cancer	3.06e-05	0.00152	CbGpPWpGaD
Nilutamide—CYP2C19—Metapathway biotransformation—CYP1A1—kidney cancer	3.02e-05	0.0015	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—ACY1—kidney cancer	3.02e-05	0.0015	CbGpPWpGaD
Nilutamide—AR—Integrated Pancreatic Cancer Pathway—MAPK3—kidney cancer	2.99e-05	0.00148	CbGpPWpGaD
Nilutamide—CYP2C9—Biological oxidations—GSTM1—kidney cancer	2.94e-05	0.00146	CbGpPWpGaD
Nilutamide—AR—Integrated Pancreatic Cancer Pathway—MYC—kidney cancer	2.91e-05	0.00144	CbGpPWpGaD
Nilutamide—CYP2C9—Metapathway biotransformation—GSTM1—kidney cancer	2.9e-05	0.00144	CbGpPWpGaD
Nilutamide—AR—Integrated Breast Cancer Pathway—TP53—kidney cancer	2.88e-05	0.00143	CbGpPWpGaD
Nilutamide—AR—Integrated Pancreatic Cancer Pathway—MAPK1—kidney cancer	2.84e-05	0.00141	CbGpPWpGaD
Nilutamide—CYP2C9—Biological oxidations—CYP1A1—kidney cancer	2.79e-05	0.00139	CbGpPWpGaD
Nilutamide—CYP2C9—Metapathway biotransformation—CYP1A1—kidney cancer	2.75e-05	0.00137	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—ACY1—kidney cancer	2.69e-05	0.00134	CbGpPWpGaD
Nilutamide—AR—Integrated Pancreatic Cancer Pathway—KRAS—kidney cancer	2.68e-05	0.00133	CbGpPWpGaD
Nilutamide—AR—Gene Expression—HSPB1—kidney cancer	2.64e-05	0.00131	CbGpPWpGaD
Nilutamide—AR—Gene Expression—EIF4EBP1—kidney cancer	2.64e-05	0.00131	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism of lipids and lipoproteins—CRABP1—kidney cancer	2.57e-05	0.00128	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—PDHB—kidney cancer	2.57e-05	0.00127	CbGpPWpGaD
Nilutamide—CYP2C8—Biological oxidations—POMC—kidney cancer	2.56e-05	0.00127	CbGpPWpGaD
Nilutamide—AR—Integrated Pancreatic Cancer Pathway—PIK3CA—kidney cancer	2.47e-05	0.00123	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—ACY1—kidney cancer	2.46e-05	0.00122	CbGpPWpGaD
Nilutamide—AR—Gene Expression—PSMD7—kidney cancer	2.45e-05	0.00122	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—CCBL1—kidney cancer	2.41e-05	0.0012	CbGpPWpGaD
Nilutamide—AR—Integrated Pancreatic Cancer Pathway—TP53—kidney cancer	2.39e-05	0.00119	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism of lipids and lipoproteins—CRABP1—kidney cancer	2.3e-05	0.00114	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—PDHB—kidney cancer	2.29e-05	0.00114	CbGpPWpGaD
Nilutamide—CYP2C19—Biological oxidations—POMC—kidney cancer	2.28e-05	0.00113	CbGpPWpGaD
Nilutamide—AR—Gene Expression—JUNB—kidney cancer	2.2e-05	0.00109	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism of lipids and lipoproteins—ACHE—kidney cancer	2.18e-05	0.00108	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—CCBL1—kidney cancer	2.15e-05	0.00107	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism of lipids and lipoproteins—CRABP1—kidney cancer	2.09e-05	0.00104	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—GLIPR1—kidney cancer	2.09e-05	0.00104	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—PPAT—kidney cancer	2.09e-05	0.00104	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—PDHB—kidney cancer	2.09e-05	0.00104	CbGpPWpGaD
Nilutamide—CYP2C9—Biological oxidations—POMC—kidney cancer	2.08e-05	0.00103	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism of lipids and lipoproteins—SCARB1—kidney cancer	2.06e-05	0.00103	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism of lipids and lipoproteins—PTGS1—kidney cancer	2.04e-05	0.00102	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—CCBL1—kidney cancer	1.96e-05	0.000975	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism of lipids and lipoproteins—ACHE—kidney cancer	1.95e-05	0.000967	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—APRT—kidney cancer	1.94e-05	0.000966	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—FH—kidney cancer	1.94e-05	0.000966	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism of lipids and lipoproteins—BCHE—kidney cancer	1.9e-05	0.000944	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—PPAT—kidney cancer	1.87e-05	0.000927	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—GLIPR1—kidney cancer	1.87e-05	0.000927	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism of lipids and lipoproteins—SCARB1—kidney cancer	1.84e-05	0.000916	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—GPC3—kidney cancer	1.83e-05	0.000908	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism of lipids and lipoproteins—PTGS1—kidney cancer	1.82e-05	0.000906	CbGpPWpGaD
Nilutamide—AR—Gene Expression—CDKN2B—kidney cancer	1.79e-05	0.000891	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—CA2—kidney cancer	1.78e-05	0.000883	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism of lipids and lipoproteins—ACHE—kidney cancer	1.78e-05	0.000882	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—FH—kidney cancer	1.74e-05	0.000862	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—APRT—kidney cancer	1.74e-05	0.000862	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—ALAD—kidney cancer	1.73e-05	0.000861	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—PPAT—kidney cancer	1.7e-05	0.000846	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—GLIPR1—kidney cancer	1.7e-05	0.000846	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism of lipids and lipoproteins—BCHE—kidney cancer	1.7e-05	0.000843	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—ST3GAL2—kidney cancer	1.69e-05	0.00084	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism of lipids and lipoproteins—SCARB1—kidney cancer	1.68e-05	0.000835	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism of lipids and lipoproteins—PTGS1—kidney cancer	1.66e-05	0.000826	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—ALDH1A1—kidney cancer	1.65e-05	0.000821	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—GPC3—kidney cancer	1.63e-05	0.000811	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—CA2—kidney cancer	1.59e-05	0.000788	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—PGK1—kidney cancer	1.58e-05	0.000787	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—SLC5A3—kidney cancer	1.58e-05	0.000787	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—FH—kidney cancer	1.58e-05	0.000786	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—APRT—kidney cancer	1.58e-05	0.000786	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—LDHB—kidney cancer	1.55e-05	0.000772	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—ALAD—kidney cancer	1.55e-05	0.000768	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism of lipids and lipoproteins—BCHE—kidney cancer	1.55e-05	0.000768	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—ST3GAL2—kidney cancer	1.51e-05	0.00075	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—GPC3—kidney cancer	1.49e-05	0.000739	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—ALDH1A1—kidney cancer	1.48e-05	0.000733	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—CA2—kidney cancer	1.45e-05	0.000719	CbGpPWpGaD
Nilutamide—AR—Generic Transcription Pathway—MYC—kidney cancer	1.44e-05	0.000717	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—SLC5A3—kidney cancer	1.41e-05	0.000703	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—PGK1—kidney cancer	1.41e-05	0.000703	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—ALAD—kidney cancer	1.41e-05	0.000701	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—LDHB—kidney cancer	1.39e-05	0.000689	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—ST3GAL2—kidney cancer	1.38e-05	0.000684	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—CA9—kidney cancer	1.35e-05	0.000669	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—ALDH1A1—kidney cancer	1.35e-05	0.000668	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism of lipids and lipoproteins—CYP1A1—kidney cancer	1.32e-05	0.000654	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—SLC5A3—kidney cancer	1.29e-05	0.000641	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—PGK1—kidney cancer	1.29e-05	0.000641	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—LDHB—kidney cancer	1.26e-05	0.000628	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—CA9—kidney cancer	1.2e-05	0.000598	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism of lipids and lipoproteins—CYP1A1—kidney cancer	1.18e-05	0.000584	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—CRABP1—kidney cancer	1.15e-05	0.000569	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—CA9—kidney cancer	1.1e-05	0.000545	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—kidney cancer	1.07e-05	0.000533	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—ITPR2—kidney cancer	1.07e-05	0.000529	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—CRABP1—kidney cancer	1.02e-05	0.000508	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism of lipids and lipoproteins—POMC—kidney cancer	9.82e-06	0.000488	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—GSTT1—kidney cancer	9.71e-06	0.000483	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—ACHE—kidney cancer	9.71e-06	0.000483	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—ITPR2—kidney cancer	9.51e-06	0.000472	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—CRABP1—kidney cancer	9.32e-06	0.000463	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—SCARB1—kidney cancer	9.19e-06	0.000457	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—PTGS1—kidney cancer	9.1e-06	0.000452	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—PSMD7—kidney cancer	8.93e-06	0.000443	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism of lipids and lipoproteins—POMC—kidney cancer	8.76e-06	0.000435	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—GSTT1—kidney cancer	8.67e-06	0.000431	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—ACHE—kidney cancer	8.67e-06	0.000431	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—ITPR2—kidney cancer	8.67e-06	0.000431	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—BCHE—kidney cancer	8.46e-06	0.00042	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—SLC5A5—kidney cancer	8.36e-06	0.000415	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—SCARB1—kidney cancer	8.21e-06	0.000408	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—PTGS1—kidney cancer	8.12e-06	0.000404	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—SLC2A1—kidney cancer	8.07e-06	0.000401	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism of lipids and lipoproteins—POMC—kidney cancer	7.99e-06	0.000397	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—PSMD7—kidney cancer	7.97e-06	0.000396	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—GSTT1—kidney cancer	7.91e-06	0.000393	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—ACHE—kidney cancer	7.91e-06	0.000393	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	7.83e-06	0.000389	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—BCHE—kidney cancer	7.55e-06	0.000375	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—SCARB1—kidney cancer	7.48e-06	0.000372	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—SLC5A5—kidney cancer	7.46e-06	0.000371	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—PTGS1—kidney cancer	7.41e-06	0.000368	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—PSMD7—kidney cancer	7.26e-06	0.000361	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—SLC2A1—kidney cancer	7.21e-06	0.000358	CbGpPWpGaD
Nilutamide—AR—Gene Expression—MAPK3—kidney cancer	7.14e-06	0.000355	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	6.99e-06	0.000347	CbGpPWpGaD
Nilutamide—AR—Gene Expression—MYC—kidney cancer	6.95e-06	0.000345	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—BCHE—kidney cancer	6.89e-06	0.000342	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	6.83e-06	0.000339	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—SLC5A5—kidney cancer	6.8e-06	0.000338	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—GSTP1—kidney cancer	6.73e-06	0.000334	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—SLC2A1—kidney cancer	6.57e-06	0.000326	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	6.37e-06	0.000317	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—ABCB1—kidney cancer	6.37e-06	0.000317	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—GSTM1—kidney cancer	6.19e-06	0.000307	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	6.1e-06	0.000303	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—GSTP1—kidney cancer	6.01e-06	0.000299	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—CYP1A1—kidney cancer	5.87e-06	0.000291	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—ABCB1—kidney cancer	5.69e-06	0.000283	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	5.56e-06	0.000276	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—GSTM1—kidney cancer	5.52e-06	0.000274	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—GSTP1—kidney cancer	5.48e-06	0.000272	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—CYP1A1—kidney cancer	5.24e-06	0.00026	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—ABCB1—kidney cancer	5.19e-06	0.000258	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—GSTM1—kidney cancer	5.04e-06	0.00025	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	4.82e-06	0.000239	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—CYP1A1—kidney cancer	4.77e-06	0.000237	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—POMC—kidney cancer	4.37e-06	0.000217	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	4.3e-06	0.000214	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	3.92e-06	0.000195	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—POMC—kidney cancer	3.9e-06	0.000194	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—POMC—kidney cancer	3.56e-06	0.000177	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—PTGS2—kidney cancer	3.49e-06	0.000173	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—PTGS2—kidney cancer	3.11e-06	0.000155	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—PTEN—kidney cancer	3.04e-06	0.000151	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—PTGS2—kidney cancer	2.84e-06	0.000141	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—PTEN—kidney cancer	2.72e-06	0.000135	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—PTEN—kidney cancer	2.48e-06	0.000123	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—PIK3CA—kidney cancer	2.15e-06	0.000107	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—PIK3CA—kidney cancer	1.92e-06	9.52e-05	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—PIK3CA—kidney cancer	1.75e-06	8.68e-05	CbGpPWpGaD
